Navigation Links
Vasogen Announces 2007 Year-End Results
Date:1/16/2008

journal. As

previously reported by Vasogen, while the trial did not meet its

primary endpoint, a key finding from the ACCLAIM trial was a

39% reduction in the risk of death or cardiovascular hospitalizations

for a large pre-specified subgroup of patients with NYHA Class II

heart failure who received Celacade therapy, compared to patients

receiving placebo.

- We entered into a collaboration with Grupo Ferrer Internacional,

S.A., a leading European pharmaceutical and medical devices company,

to commercialize Celacade for the treatment of chronic heart failure

in specified countries of the European Union and in certain Latin

American countries. In December 2007, Ferrer received initial orders

for Celacade in Germany.

- The Food and Drug Administration strongly recommended that we conduct

a confirmatory study (ACCLAIM-II) in NYHA Class II heart failure

patients to support a Pre-market Approval filing for Celacade in the

United States. The FDA also recommended that we utilize a Bayesian

statistical approach for designing the confirmatory trial as it would

allow for the borrowing of statistical power from the ACCLAIM study.

This approach has the potential to substantially reduce the number of

patients required for a confirmatory study, as well as the cost and

duration.

- James B. Young, MD, Chairman, Division of Medicine at the Cleveland

Clinic Foundation and Medical Director, Kaufman Center for Heart

Failure, was appointed the Global Principal Investigator and Chairman

of the Steering Committee for ACCLAIM-II.

- Chris Waddick, MBA, CMA, was appointed President, CEO, and a Member

of the Board of Directors of our Company. Mr. Waddick has held a

series of progressive senior management positions at Vasog
'/>"/>

SOURCE Vasogen Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Vasogen Announces Third Quarter Conference Call and Webcast of Bio InvestorForum 2007 Presentation
2. Vasogen Announces Third Quarter 2007 Results
3. Vasogen to Webcast Presentations at Three Upcoming Healthcare Conferences
4. Vasogen Provides an Update on ACCLAIM-II Preparations
5. Vasogen and Grupo Ferrer Announce Initial Roll-out of Celacade - New Therapy for Chronic Heart Failure
6. Vasogen to Conduct Year-end 2007 Conference Call
7. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
8. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
9. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
10. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
11. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... (PRWEB) August 28, 2014 Whitehouse Laboratories ... long term partnership with PTI Inspection Systems ... with state of the art leak testing method development ... art instruments currently available. As part of this agreement, ... High Voltage Leak Detection Instrument developed and manufactured ...
(Date:8/27/2014)... 2014 Reportlinker.com announces that a ... its catalogue: Global Biodegradable Packaging ... http://www.reportlinker.com/p02316661/Global-Biodegradable-Packaging-Materials-Market-2014-2018.html About Biodegradable Packaging ... readily decomposed by the action of microorganisms. ... in terms of raw materials, production technology, ...
(Date:8/27/2014)... Aug. 27, 2014 Research and ... "Global Lactic Acid  (Biodegradable Polymer, Food & Beverage, ... Forecasts to 2019" report to their offering. ... acid with an asymmetrical carbon atom. The main ... polymer, food and beverage, personal care product, and ...
(Date:8/27/2014)... Aug. 27, 2014 Reportbuyer.com has added ... Graphene Opportunity - A Rational View ... New Nanotech? A similar amount of hype ... ranging from microelectronics to water treatment, but is ... availability of the Graphene Opportunity Report, authored by ...
Breaking Biology Technology:Whitehouse Labs Renews Partnership with PTI Inspection Systems 2Whitehouse Labs Renews Partnership with PTI Inspection Systems 3Global Biodegradable Packaging Materials Market 2014-2018 2Global Biodegradable Packaging Materials Market 2014-2018 3Global Biodegradable Packaging Materials Market 2014-2018 4Global Biodegradable Packaging Materials Market 2014-2018 5Global Biodegradable Packaging Materials Market 2014-2018 6Global Biodegradable Packaging Materials Market 2014-2018 7Global Lactic Acid (Biodegradable Polymer, Food & Beverage, Personal Care & Pharmaceutical) Market - Trends & Forecasts to 2019 2The Graphene Opportunity - A Rational View 2The Graphene Opportunity - A Rational View 3The Graphene Opportunity - A Rational View 4
... PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI ) today announced ... stockholders, with part of the proceeds from the $300 million ... shares of PDL on December 1, 2009 will be paid ... a significant amount of convertible securities outstanding, the amount of ...
... ... ... 12, 2009 – Tackling global food security requires an understanding of local situations ... international scale, DuPont Vice President and Pioneer Hi-Bred Chairman Dean Oestreich told a ...
... RIDGE, N.J., Nov. 12 Regado Biosciences, a privately ... active control agents, announced that David Mazzo, PhD, CEO ... Markets 6th Annual Healthcare Conference at the St. Regis ... be given at 1:10pm (EST) on Tuesday, November 17 ...
Cached Biology Technology:PDL BioPharma Announces Special Dividend Payment 2Start Locally, Collaborate to Increase Food Security, Says DuPont Leader to U.N. Group 2Start Locally, Collaborate to Increase Food Security, Says DuPont Leader to U.N. Group 3Start Locally, Collaborate to Increase Food Security, Says DuPont Leader to U.N. Group 4Regado Biosciences to Present at the Lazard Capital Markets 6th Annual Healthcare Conference on November 17, 2009 2
(Date:8/27/2014)... , Aug. 27, 2014 /PRNewswire-iReach/ -- The IEEE Engineering ... 36 th Annual International Conference (EMBC,14), this year ... in Chicago, Illinois , from Tuesday, ... global leaders, students, and industry professionals in science, medicine, ... - http://photos.prnewswire.com/prnh/20140827/140333 This year,s ...
(Date:8/27/2014)... long-standing belief that a deficiency in serotonin a ... role in depression. In the journal ACS Chemical ... to make serotonin in their brains (and thus should ... depression-like symptoms. , Donald Kuhn and colleagues at ... State University School of Medicine note that depression poses ...
(Date:8/27/2014)... thought to be associated with outcomes after the ... of the patient, mechanism of injury, nerve injured, ... operation technique, and repair materials. However, despite numerous ... nerve injuries, there is no agreement regarding the ... dose-effect relationship of the predictors has not been ...
Breaking Biology News(10 mins):Global Leaders In Science, Medicine, And Engineering Gather For The 36th Annual International Conference Of The IEEE Engineering In Medicine And Biology Society, August 26-30 In Chicago 2Global Leaders In Science, Medicine, And Engineering Gather For The 36th Annual International Conference Of The IEEE Engineering In Medicine And Biology Society, August 26-30 In Chicago 3New study throws into question long-held belief about depression 2
... can sail throughout the body via the bloodstream without ... ferry their cargo of anti-cancer drugs and markers into ... In a forthcoming issue of the Germany-based chemistry journal ... UC Santa Barbara and MIT report that their nano-cargo-ship ...
... North Hollywood, CA September 11, 2008 - ... advocacy and support for myeloma patients, families, researchers and ... with multiple myeloma, cancer in the bone marrow that ... edition of the Journal of Clinical Oncology *, ...
... are bracing for Hurricane Ike as it travels over the ... Envisat satellite is tracking the storm, which is forecast to ... Knowing the strength and path of hurricanes is critical for ... of providing synoptic data on the forces that power the ...
Cached Biology News:Researchers develop nano-sized 'cargo ships' to target and destroy tumors 2Researchers develop nano-sized 'cargo ships' to target and destroy tumors 3Researchers develop nano-sized 'cargo ships' to target and destroy tumors 4The IMF says journal editorial documents dramatic increase in survival since the 1980s 2Hurricane Ike tracked by ESA's Envisat 2
...
... Solution, High pH, Concentrated x 10 ... heat-induced target retrievel prior to immunohistochemical staining ... paraffin-embedded tissue sections mounted on glass slides. ... pH, 9.9, is especially effective. It should ...
... solid. Increases the expression of glutathione peroxidase. ... 2 O. Unstable in aqueous solutions; reconstitute ... 3211-76-5, M.W. 196.1. References: Merck Index ... A.F. 1995. Biochem. J. 306, ...
... UN-SCAN-IT gel Software converts any scanner into ... numerous options and features, the basic operation ... JPEG, PCX, BMP, etc.) into pixel density ... steps. Turn your scanner ...
Biology Products: